Patents by Inventor John Herrmann
John Herrmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8541107Abstract: The present disclosure is directed to a base film having a thickness from 8 to 152 microns, a 60 degree gloss value from 2 to 35, an optical density greater than or equal to 2 and a dielectric strength greater than 1400 V/mil. The base film comprises a chemically converted (partially or wholly aromatic) polyimide in an amount from 63 to 96 weight percent of the base film. The base film further comprises a pigment and a matting agent. The matting agent is present in an amount from 1.6 to 10 weight percent of the base film, has a median particle size from 1.3 to 10 microns, and has a density from 2 to 4.5 g/cc. The pigment is present in an amount from 2 to 35 weight percent of the base film. The present disclosure is also directed to coverlay films comprising the base film in combination with an adhesive layer.Type: GrantFiled: August 5, 2010Date of Patent: September 24, 2013Assignee: E. I. du Pont de Nemours and CompanyInventors: Thomas Edward Carney, Jeffrey Michael Bartolin, Meredith L Dunbar, Scott John Herrmann
-
Publication number: 20130236717Abstract: The present disclosure is directed to a base film having a thickness from 8 to 152 microns, a 60 degree gloss value from 2 to 35, an optical density greater than or equal to 2 and a dielectric strength greater than 1400 V/mil. The base film comprises a chemically converted (partially or wholly aromatic) polyimide in an amount from 63 to 96 weight percent of the base film. The base film further comprises a pigment and a matting agent. The matting agent is present in an amount from 1.6 to 10 weight percent of the base film, has a median particle size from 1.3 to 10 microns, and has a density from 2 to 4.5 g/cc. The pigment is present in an amount from 2 to 35 weight percent of the base film. The present disclosure is also directed to coverlay films comprising the base film in combination with an adhesive layer.Type: ApplicationFiled: April 29, 2013Publication date: September 12, 2013Applicant: E.I. Du Pont De Nemours and CompanyInventors: Thomas Edward Carney, Jeffrey Michael Bartolin, Meredith L. Dunbar, Scott John Herrmann
-
Publication number: 20130196134Abstract: The present disclosure is directed to a base film having a thickness from 8 to 152 microns, a 60 degree gloss value from 2 to 35, an optical density greater than or equal to 2 and a dielectric strength greater than 1400 V/mil. The base film comprises a chemically converted (partially or wholly aromatic) polyimide in an amount from 71 to 96 weight percent of the base film. The base film further comprises a pigment and a matting agent. The matting agent is present in an amount from 1.6 to 10 weight percent of the base film, has a median particle size from 1.3 to 10 microns, and has a density from 2 to 4.5 g/cc. The pigment is present in an amount from 2 to 9 weight percent of the base film. The present disclosure is also directed to coverlay films comprising the base film in combination with an adhesive layer.Type: ApplicationFiled: February 14, 2011Publication date: August 1, 2013Applicant: E I DU PONT DE NEMOURS AND COMPANYInventors: Thomas Edward Carney, Jeffrey Michael Bartolin, Meredith L. Dunbar, Scott John Herrmann
-
Patent number: 8440315Abstract: The present disclosure is directed to a base film having a thickness from 8 to 152 microns, a 60 degree gloss value from 2 to 35, an optical density greater than or equal to 2 and a dielectric strength greater than 1400 V/mil. The base film comprises a chemically converted (partially or wholly aromatic) polyimide in an amount from 71 to 96 weight percent of the base film. The base film further comprises a pigment and a matting agent. The matting agent is present in an amount from 1.6 to 10 weight percent of the base film, has a median particle size from 1.3 to 10 microns, and has a density from 2 to 4.5 g/cc. The pigment is present in an amount from 2 to 9 weight percent of the base film. The present disclosure is also directed to coverlay films comprising the base film in combination with an adhesive layer.Type: GrantFiled: June 1, 2012Date of Patent: May 14, 2013Inventors: Thomas Edward Carney, Jeffrey Michael Bartolin, Meredith L. Dunbar, Scott John Herrmann
-
Patent number: 8387321Abstract: A connector for a wall structure wherein the connector connects to and reinforces a stud within the wall structure, or in some cases, the connector actually functions as a stud. The connector includes an elongated web and a pair of flanges that project from the web. About the lower portion of the connector there is provided a series of tabs that extend from the web and the two flanges and are turned so as to overlap and form a transfer structure that extends between the flanges about the lower end of the connector. In use, the connector can be connected to respective studs in a wall structure and at the same time anchor to an underlying structure such as a floor. In other cases, the connector itself can be utilized in the wall structure as a stud.Type: GrantFiled: May 19, 2009Date of Patent: March 5, 2013Assignee: The Steel Network, Inc.Inventors: Edward R. diGirolamo, John Herrmann, Nabil Abdel-Rahman
-
Publication number: 20130022597Abstract: The present invention provides fully human monoclonal antibodies that specifically bind to GPNMB, and uses thereof. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDRs) are provided. The present invention also provides immunoconjugates comprising anti-GPNMB antibodies and methods of using such immunoconjugates. The present invention further provides bi-specific antibodies comprising an anti-GPNMB antibody component and an anti-CD3 component, and methods of using such bispecific antibodies.Type: ApplicationFiled: January 20, 2012Publication date: January 24, 2013Inventors: Meina Liang, Orit Foord, Scott Klakamp, Vincent A. Pollack, Luca Rastelli, John Herrmann, Henri Lichenstein, Michael Jeffers, William LaRochelle, Peter Mezes, Andrei Chapoval, Cyrus Karkaria, Michael Torgov, Juan Davagnino
-
Publication number: 20120251808Abstract: The present disclosure is directed to a base film having a thickness from 8 to 152 microns, a 60 degree gloss value from 2 to 35, an optical density greater than or equal to 2 and a dielectric strength greater than 1400 V/mil. The base film comprises a chemically converted (partially or wholly aromatic) polyimide in an amount from 71 to 96 weight percent of the base film. The base film further comprises a pigment and a matting agent. The matting agent is present in an amount from 1.6 to 10 weight percent of the base film, has a median particle size from 1.3 to 10 microns, and has a density from 2 to 4.5 g/cc. The pigment is present in an amount from 2 to 9 weight percent of the base film. The present disclosure is also directed to coverlay films comprising the base film in combination with an adhesive layer.Type: ApplicationFiled: June 1, 2012Publication date: October 4, 2012Applicant: E. I. DU PONT DE NEMOURS AND COMPANYInventors: THOMAS EDWARD CARNEY, JEFFREY MICHAEL BARTOLIN, MEREDITH L. DUNBAR, SCOTT JOHN HERRMANN
-
Publication number: 20100126103Abstract: A connector for a wall structure wherein the connector connects to and reinforces a stud within the wall structure, or in some cases, the connector actually functions as a stud. The connector includes an elongated web and a pair of flanges that project from the web. About the lower portion of the connector there is provided a series of tabs that extend from the web and the two flanges and are turned so as to overlap and form a transfer structure that extends between the flanges about the lower end of the connector. In use, the connector can be connected to respective studs in a wall structure and at the same time anchor to an underlying structure such as a floor. In other cases, the connector itself can be utilized in the wall structure as a stud.Type: ApplicationFiled: May 19, 2009Publication date: May 27, 2010Applicant: THE STEEL NETWORK, INC.Inventors: Edward R. diGirolamo, John Herrmann, Nabil Abdel-Rahman
-
Publication number: 20080186185Abstract: Methods and apparatuses for the protection of radio frequency identification (RFID) devices are described. In one aspect, a static dissipative material is applied to a web of antenna structures. A coating of the static dissipative material is applied continuously across a plurality of antenna structures of a roll of the web material. An RFID integrated circuit (IC) is attached to the web of antenna structures with the dissipative coating, then subsequently tested on the roll. Additional processing is performed to the RFID tag to produce an RFID label.Type: ApplicationFiled: February 4, 2008Publication date: August 7, 2008Inventors: Scott John Herrmann, Mark Alfred Hadley, Gordon Samuel Wiggins Craig, John Berhard Hattick, Paul Stephen Drzaic, Eric Ryan Kanemoto
-
Publication number: 20080171046Abstract: Disclosed herein are novel human nucleic acid sequences which encode polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.Type: ApplicationFiled: May 12, 2004Publication date: July 17, 2008Inventors: Corine Vermet, Elma Fernandes, Richard Shimkets, John Herrmann, Kumud Majumder, John MacDougall, Vishnu Mishra, Peter S. Mezes, Luca Rastelli
-
Patent number: 7342490Abstract: Methods and apparatuses for the protection of radio frequency identification (RFID) devices are described. In one aspect, a static dissipative material is applied to a web of antenna structures. A coating of the static dissipative material is applied continuously across a plurality of antenna structures of a roll of the web material. An RFID integrated circuit (IC) is attached to the web of antenna structures with the dissipative coating, then subsequently tested on the roll. Additional processing is performed to the RFID tag to produce an RFID label.Type: GrantFiled: November 23, 2004Date of Patent: March 11, 2008Assignee: Alien Technology CorporationInventors: Scott John Herrmann, Mark Alfred Hadley, Gordon Samuel Wiggins Craig, John Berhard Hattick, Paul Stephen Drzaic, Eric Ryan Kanemoto
-
Publication number: 20070178452Abstract: Disclosed is a method in which DNA sequences derived from microsome-associated mRNA sequences in a mixed sample or in an arrayed single sequence clone can be determined and classified without sequencing. The methods make use of information on the presence of carefully chosen target subsequences, typically of length from 4 to 8 base pairs, and preferably the length between target subsequences in a sample DNA sequence together with DNA sequence databases containing lists of sequences likely to be present in the sample to determine a sample sequence. The preferred method uses restriction endonucleases to recognize target subsequences and cut the sample sequence. Then carefully chosen recognition moieties are ligated to the cut fragments, the fragments amplified, and the experimental observation made. Polymerase chain reaction (PCR) is the preferred method of amplification.Type: ApplicationFiled: October 21, 2002Publication date: August 2, 2007Inventors: Pascal Bouffard, John Herrmann, Chunli Huang, Michael Jeffers, Jingfang Ju, Luca Rastelli, Juliette Shimkets, Jan Simons, Bruce Taillon
-
Patent number: 7162655Abstract: Power supply response to variations in power demand by a microprocessor is improved with a compensation loops that estimate changes in load current with improved speed. The load current estimate is performed in part with a capacitance feed forward compensation loop that senses voltage at output capacitors to replicate the current present in the capacitors and communicates the capacitor current adjusted by an optimized gain to the power supply for adjustment of power output. Capacitor current is replicated with a frequency domain filter having a pole that cancels out the zero created by power supply equivalent series resistance and capacitor capacitance. The capacitance compensation loop improves power supply response time to microprocessor power demand skews so that the size or number of output capacitors may be reduced while still maintaining power supply at the microprocessor to within desired voltage and current tolerances.Type: GrantFiled: July 16, 2003Date of Patent: January 9, 2007Assignee: Dell Products, L.P.Inventors: Brent A. McDonald, John A. Herrmann, Daniel E. Jenkins
-
Patent number: 7141549Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.Type: GrantFiled: February 8, 2005Date of Patent: November 28, 2006Inventors: Peter Mezes, Luca Rastelli, John Herrmann, John MacDougall, Haihong Zhong, Stacie Casman, Ferenc Boldog, Richard Shimkets, Linda Gorman, Andrew Eisen, Steven Spaderna, Corine Vernet, Constance Berghs, Kimberly Spytek, Vincent DiPippo, Bryan Zerhusen, John Peyman, Karen Ellerman, David Stone, William Grosse, John Alsobrook, II, Denise Lepley, Daniel Rieger, Catherine Burgess, Shlomit Edinger, Edward Voss, Charles Miller
-
Publication number: 20060084054Abstract: The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.Type: ApplicationFiled: June 4, 2003Publication date: April 20, 2006Inventors: John Alsobrook, David Anderson, Jason Baumgartner, Constance Berghs, Ferenc Boldog, Catherine Burgess, Stacie Casman, Elina Catterton, Mohanraj Dhanabal, Shlomit Edinger, Karen Ellerman, Seth Ettenberg, Esha Gangolli, Valerie Gerlach, Linda Gorman, William Grosse, Erik Gunther, Xiaojia Guo, Vladimir Gusev, John Herrmann, Weizhen Ji, Ramesh Kekuda, Nikolai Khramtsov, William LaRochelle, Li Li, Hongping Liang, Kenneth Low, John MacDougall, Timothy Maclachlan, Uriel Malyankar, Kelly McQueeney, Amanda Mezick, Charles Miller, Isabelle Millet, Muralidhara Padigaru, Meera Patturajan, John Peyman, Xiaozhong Qian, Luca Rastelli, Daniel Rieger, Mark Rothenberg, Suresh Shenoy, Richard Shimkets, Glennda Smithson, Kimberly Spytek, David Stone, Sujatha Sukumaran, Edward Szekeres, Corine Vernet, Edward Voss, Adam Wolenc, Mei Zhong, Haihong Zhong
-
Publication number: 20060013813Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.Type: ApplicationFiled: February 8, 2005Publication date: January 19, 2006Inventors: Peter Mezes, Luca Rastelli, John Herrmann, John MacDougall, Haihong Zhong, Stacie Casman, Frenc Boldog, Richard Shimkets, Linda Gorman, Andrew Eisen, Steven Spaderna, Corine Vernet, Constance Berghs, Kimberly Spytek, Vincent DiPippo, Bryan Zerhusen, John Peyman, Karen Ellerman, David Stone, William Grosse, John Alsobrook, Denise Lepley, Daniel Rieger, Catherine Burgess, Sholmit Edinger, Edward Voss, Charles Miller
-
Publication number: 20060003323Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.Type: ApplicationFiled: June 3, 2003Publication date: January 5, 2006Inventors: John Alsobrook, Enrique Alvarez, David Anderson, Ferenc Boldog, Stacie Casman, Elina Catterton, Andrei Chapoval, Julie Crabtree-Bokor, Shlomit Edinger, Karen Ellerman, Seth Ettenberg, Esha Gangolli, Valerie Gerlach, Linda Gorman, Erik Gunther, Xiaojia (Sasha) Guo, Vladimir Gusev, John Herrmann, Weizhen Ji, Ramesh Kekuda, Li Li, Xiaohong Liu, John MacDougall, Timothy Machlachlan, Uriel Malyankar, Amanda Mezick, Isabelle Millet, Vishnu Mishra, Muralidhara Padigaru, Meera Patturajan, Carol Pena, John Peyman, Debasish Raha, Luca Rastelli, Daniel Rieger, Mark Rothenberg, Paul Sciore, Suresh Shenoy, Richard Shimkets, Glennda Smithson, Kimberly Spytek, David Stone, Corine Vernet, Edward Voss, Mei Zhong, Hiahong Zhong
-
Publication number: 20050285572Abstract: A battery protection circuit is provided that includes current monitoring circuit. The current monitoring circuit senses current flowing to or from a rechargeable cell. When the current exceeds a maximum value, the current monitoring circuit actuates, whereby opening a transistor. The transistor has a resistor couple in parallel. When the transistor opens, current is forced through the resistor coupled in parallel with the transistor, thereby limiting the current to a maximum value. The current monitoring circuit also simulates an overcurrent condition in the safety circuit. The overcurrent condition causes a disconnect switch to open, thereby disconnecting the cell(s) from the external terminals.Type: ApplicationFiled: June 29, 2004Publication date: December 29, 2005Inventors: Michael Geren, Jennifer Collier, John Herrmann
-
Publication number: 20050269989Abstract: A cell balancing circuit monitors the voltage between serially connected cells and compares it to a reference voltage. From that comparison, the cell balancing circuit sources or sinks current into a midpoint node between rechargeable cells to keep the cells balanced during the charging process. In one preferred embodiment, the cell balancing circuit includes an op-amp, connected in a unity gain configuration. A voltage divider establishes a reference voltage equal to the average of the two cell voltages. The op-amp compares this average to the measured voltage at the midpoint node. When the average voltage exceeds the voltage at the midpoint node, the op-amp sources current into the midpoint node. When the average voltage falls below the voltage at the midpoint node, the op-amp sinks current from the midpoint node. By sourcing or sinking current, the cell balancing circuit allows the lesser charged cell to catch up with the more fully charged cell.Type: ApplicationFiled: June 5, 2004Publication date: December 8, 2005Inventors: Michael Geren, John Oglesbee, John Herrmann, Stephanie Smith, Roger Boyer
-
Publication number: 20050171020Abstract: Disclosed are novel nucleic acids encoding proteins and polypeptides related to bone morphogenetic protein-1 (BMF1) and to vascular endothelial growth factor E (VEGF-E).Type: ApplicationFiled: April 1, 2005Publication date: August 4, 2005Inventors: Richard Shimkets, Henri Lichenstein, John Herrmann, Ferenc Boldog